MedSuds First Annual Stem Cell Conference

Home

Register

Agenda

Sponsors

Media

Join MedSuds

Web Forum

Contact Us

MN VC Conference

MN M&A Conference

NetSuds

Co-hosted by

American-Israel Chamber of Commerce of Minnesota

Elliot Park Life Sciences Institute

MedSuds™
980 Lake Susan Hills Drive
Chanhassen, MN 55317
Phone: 1.612.605.5252
Fax: 1.612.677.3934

Webcast Now Available

The Minnesota Stem Cell Conference was held November 16 at the Pillsbury Auditorium at the Hennepin County Medical Center in Minneapolis, Minnesota.

The entire conference is available in recorded format on the Internet. The attendee list is also available. You can still Register to view the archived webcast and obtain the attendee list. The webcast includes PowerPoint presentations and audio streaming of the entire conference.

Those who should be interested include researchers, academicians, clinicians, medtech professionals, biotech professionals, ethicists, legislators, theologians, investors, business leaders and other interested parties.

Here is what Minnesota law currently states on matters related to embryonic stem cell research: 145.421 145.422

Here is what the Minneapolis Star-Tribune wrote about the conference on page 1 of the Business section on November 17.

Matt Noah, Conference Chairman, matt@medsuds.com

Agenda

7:00 am

Registration and Name Badge Pick-Up Opens

8:00 am

Conference Welcome.
	Matt Noah, Conference Chairman.

8:15 am

Medical Status of Adult and Embryonic Stem Cell Research
	Robert S. Schwartz, MD, FACC, Cardiologist, Minneapolis Heart Institute (MN).

8:45 am

Stem Cell Commercialization at BioE
	Michael Haider, CEO, BioE (MN).

9:15 am

Stem Cell Commercialization at NewNeural
	Robert Gonzalez, President & CEO, NewNeural (WI)

9:45 am

Preservation and Processing of Stem Cells
	Prof. Allison Hubel, Ph.D., Associate Professor of Mechanical Engineering and Laboratory Medicine and Pathology, University of Minnesota (MN).

10:00 am

Break

10:30 am

Investing in Stem Cell Companies: Perspectives From Venture Capitalists and Business Executives on the Prospects of Stem Cell companies and the appetite for risk among investors in stem cell companies.

David Andresen, Corporate Finance, Cornell Capital Partners (CA)
Peter Allison, Managing Partner, BioGenetic Ventures (ID)
Harlan Jacobs, President, Genesis Business Centers (MN)

11:30

Lunch (on your own)

1:00 pm

Moral and Ethical Concerns of Embryonic Stem Cell Research: What are leading ethicists and theologians saying about the moral and ethical aspects of ESCR. Hear the arguments. Ask your questions. Note: Over 30 leading pro-ESCR etchicists and theologians turned down our offer to participate in this dialogue.

Rev. Tadeusz Pacholczyk, Ph.D., Director of Education, The National Catholic Bioethics Center (PA)
Paul Wojda, Ph. D., Assistant Professor of Theology, University of St. Thomas (MN)

2:00 pm

Break

2:15 pm

Stem Cell Politics: Minnesota Law, State Budget, the University of Minnesota, California Proposition 71 and what it means for California and the other 49 states.

Steve Kelley (DFL), Majority Whip, Minnesota State Senate (MN)
	Dr. H. Rex Greene, Medical Director, Dorothy E. Schneider Cancer Center (CA)**
		Wesley Smith, Senior Fellow, Discovery Institute (CA)**
Steve Sviggum (R), Speaker of the Minnesota House of Representatives (MN). Speaker Sviggum has backed out of attending and speaking at the Conference for no apparent reason. His staff provided no conflicting reason and refused to provide further comment. He cancelled late last week, with no time to schedule a back-up speaker from the MN State House.

3:30 pm

Break

3:45 pm

A Prognosis for Stem Cell Research Translating to Commercial Applications
	Dr. Maura Donovan, Director, Biosciences R&D, and Bakken Fellow, Medtronic.

4:30 pm

Matt Noah and Adjournment